The need for a blueprint emergency plan to avoid a HPAPI crisis
SMi reports: Taro Pharmaceuticals, Purdue Pharma and Sakari Consultants to present at HPAPI USA taking place on October 21st – 22nd in Boston
With a massive growth within the HPAPI market, manufacturers cannot afford to be complacent in terms of staff training, utilization of approved technology and blueprint accident plans. Straying away from the correct procedures can have a massive affect on your business and industry.
At the inaugural HPAPI USA conference, these issues will be discussed and give delegates the opportunity to hear from industry experts who will share their experiences and arm attendees with the safety strategies to implement into their organization.
Ayasha Ovals from Taro Pharmaceuticals will provide a keynote address on Day One of the conference, where she will give insights into emergency procedures for HPAPI disasters and how to manage an accident, including long term cost savings, managing risk, fail-safe procedure and forward planning.
Industrial hygiene and potent compound containment will be discussed by Joseph Grill, former Associate Director from Purdue Pharma, where he will share insights on common pitfalls in industrial hygiene, flexible containment and the potential of hastening R&D.
Sakari Consultants, President & Principle, Patricia Weideman will focus on training and managing workers with HPAPI exposure, along with the best available techniques for cleaning and waste management. She will also look at technological innovations for containment and transfer technologies, ensuring staff are sufficiently trained and ensure they understand the equipment they are utilising.
The programme with full speaker line-up is available to download at www.hpapi-usa.com
Plus, two HPAPI USA Post Conference Workshops will take place in Boston on October 23rd:
Workshop A: The roadmap from assessing HPAPI hazards to containment implementation along with CDMO dynamics hosted by Dr Janet Gould, Principal Toxicologist, SafeBridge Consultants and Charlyn Reihamn, Principle Occupational Health Consultant, SafeBridge Consultants
Workshop B: How to sell your containment project to management: financial justification for containment solutions hosted by Dr David Eherts, Vice President Global EHS, Allergan Inc
For those interested, an early bird saving of $300 is available for conference tickets booked before Friday 28th June. Register online at www.hpapi-usa.com/pr3
Sponsored by BSP Pharmaceuticals, LONZA, Minakem, SafeBridge Consultants
Highly Potent Active Pharmaceutical Ingredients USA
Conference: October 21st – 22nd
Workshops: October 23rd
Venue: Sheraton Boston Hotel, USA
For delegate enquiries, please contact Fateja Begum on +44 (0)20 7827 6184 or email@example.com
For sponsorship, exhibition and branding enquiries, please contact Alia Malick on +44 (0)20 7827 6168 or firstname.lastname@example.org
For media enquiries contact Neill Howard on Tel: +44 (0)20 7827 6164 or email@example.com